Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 5,219articles · 365d
- 2+ day agolatest article
- Sep 14, 2025earliest in window
- 87%with images
- 303avg words
- Medical 2,725
- Health & Wellness 2,685
- Economy, Business & Finance 2,581
- Finance & Business 1,826
- Business & Industrial 1,702
- Health 1,619
- Science & Technology 817
- News 672
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
2+ day, 13+ hour ago (313+ words) NEW YORK and ATHENS, Greece, Sept. 10, 2026 /PRNewswire/ -- Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael Kalos, PhD, as Venture Partner. Dr. Kalos brings decades of biopharmaceutical executive leadership, drug discovery,…...
Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
3+ day, 5+ hour ago (429+ words) BioSpace Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline CAMBRIDGE, England--(BUSINESS WIRE)--Clinical-stage biotech Alchemab Therapeutics has appointed experienced pharma and biotech leader Dr Ben Porter-Brown as Chief…...
Takeda’s long-term R&D head announces exit after major pipeline reorganization
2+ day, 22+ hour ago (499+ words) iStock, Agdekon Media Visuals Takeda’s R&D chief Andy Plump will say good-bye to the drugmaker, with a retirement slated for next summer. “Andy has made the personal decision to retire in June 2027 after more than 10 years leading Takeda’s global…...
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
3+ day, 23+ min ago (221+ words) Ginkgo plans to build the automation hardware and control software for ESCALATOR, a continuous-flow, autonomous manufacturing system designed to produce and quality-release RNA drug products at patient scale Ginkgo’s Role: Making Twenty Instruments Behave as One System Ginkgo is building…...
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs
3+ day, 27+ min ago (140+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Encoded raises $275M series F for Dravet syndrome gene therapy
3+ day, 2+ hour ago (423+ words) Encoded Therapeutics has closed a $275 million series F round to help advance its investigational Dravet syndrome therapy into pivotal development. Much of the proceeds will go toward Encoded’s lead asset ETX101, according to a Wednesday release. The therapy is being tested…...
Definium Therapeutics to Present Topline Data from Phase 3 Emerge and Voyage Trials Across Major Depressive Disorder and Generalized Anxiety Disorder at Psych Congress 2026
3+ day, 7+ hour ago (205+ words) Emerge Phase 3 study podium poster to be featured in “Latest Discoveries & Emerging Trends in MDD” session New epidemiological research on risks associated with anxiety and depression plus five posters across clinical program NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium…...
From process to intelligence: How AI is reshaping people strategy in life sciences
3+ day, 8+ hour ago (401+ words) BioSpace Applying artificial intelligence and automation tactics has played a large role in talent strategy conversations in the past few years While many organizations initially focused on experimenting with tools and driving adoption to create efficiencies, leading employers are now…...
August biopharma layoffs impact just over 500, down 90% year over year
3+ day, 8+ hour ago (442+ words) The biopharma layoff picture improved year over year in August, based on BioSpace tallies. The number of biotech and pharma companies cutting or projecting they’ll cut their workforces fell 48% to 12, while affected employees plunged 90% to 526. Encouraging year-over-year layoff data for…...
Tevard Biosciences Announces Publication of Preclinical Research Supporting Engineered Suppressor tRNAs for Duchenne Muscular Dystrophy
3+ day, 20+ hour ago (1720+ words) BioSpace - Collect information about your geographical location which can be accurate to within several meters - Identify your device by actively scanning it for specific characteristics (fingerprinting) Some of the data collected by this provider is for the purposes of personalization…...